Avtar S Bassin, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13352 N 83rd Ave, Suite #a 100, Peoria, AZ 85381 Phone: 623-977-8871 Fax: 623-977-4826 |
Shannon Patrice Valenzuela, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13634 N. 93rd Ave, Suite 100, Peoria, AZ 85381 Phone: 623-933-0301 Fax: 623-933-0224 |
Dr. Abdullah M Yonan, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9171 W Thunderbird Rd, Suite 101, Peoria, AZ 85381 Phone: 623-815-7800 Fax: 623-815-7900 |
Jack Steven Tuber, DO Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6818 W Thunderbird Rd, Peoria, AZ 85381 Phone: 623-566-3550 Fax: 623-566-3573 |
Dr. Amit Dhingra, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13634 N 93rd Ave Ste 100, Peoria, AZ 85381 Phone: 623-933-0301 Fax: 623-933-0224 |
Girish Himatlal Mehta, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13634 North 93rd Avenue, Suite 100, Peoria, AZ 85381 Phone: 623-933-0301 Fax: 623-933-0224 |
Gagandip B Singh, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13634 N 93rd Ave Ste 100, Peoria, AZ 85381 Phone: 239-330-3016 Fax: 602-933-0224 |
News Archive
As many as 80 percent of lungs from organ donors are not used, either because they are not in good enough condition to transplant, or there are doubts about their quality and there is no way to verify their condition.
Work-related stress encountered by construction workers and the impact it has on performance, the risk of accidents, and costs to employers will be investigated thanks to a Ā£25,000 research grant.
Conventional biological wisdom holds that living cells interact with their environment through an elaborate network of chemical signals. As a result many therapies for the treatment of cancer and other diseases in which cell behavior goes awry focus on drugs that block or disrupt harmful chemical signals.
Lundbeck Inc. ("Lundbeck"), a wholly owned subsidiary of H. Lundbeck A/S in Denmark (Copenhagen: LUN), announced today that SabrilĀ® (vigabatrin) Tablets and Powder for Oral Solution are now available for prescribing in the United States.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.
› Verified 1 days ago